Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors
- 23 December 2016
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 1 (6)
Abstract
Anti–RSV F antibody repertoire profiling reveals new opportunities for vaccine design and passive therapy.Keywords
This publication has 58 references indexed in Scilit:
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human seraScience Translational Medicine, 2015
- Architecture of respiratory syncytial virus revealed by electron cryotomographyProceedings of the National Academy of Sciences, 2013
- Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyScience, 2013
- Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical interventionProceedings of the National Academy of Sciences, 2012
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing EpitopesJournal of Virology, 2011
- Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titersProceedings of the National Academy of Sciences, 2011
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine developmentImmunological Reviews, 2010
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro : Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutantProceedings of the National Academy of Sciences, 1997
- Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial VirusThe Journal of Infectious Diseases, 1997